NL-OMON25583已完成不适用
Intravitreal versus submacular injection of rtPA for acute submacular haemorrhages.
The Rotterdam Eye HospitalPO Box 70030 3000 LM Rotterdam0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
de Jong JH, van Zeeburg EJ, Cereda MG, van Velthoven ME, Faridpooya K, Vermeer KA, van Meurs JC. Intravitreal versus subretinal administration of recombinant tissue plasminogen activator combined with gas for acute submacular hemorrhages due to age-related macular degeneration: An Exploratory Prospective Study. Retina. 2016; 36(5): 914-925
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Informed consent;
- •2. Age > 45;
排除标准
- •1. INR>2 (or when treating cardiologist does not allow an INR<2);
- •2. Known etiology of SMH other than exudative AMD;
研究者
相似试验
进行中（未招募）
1 期
Intravitreal versus submacular injection of rtPA for acute submacular haemorrhages. - rtPA for acute submacular haemorrhagesacute submacular haemorrhageEUCTR2010-023636-17-NLThe Rotterdam Eye Hospital25
暂停
不适用
rt-PA administration by retinal branch vein route for Central Retinal Vein Occlusion (CRVO). A Randomized - Conventional Therapy controlled – Trial.Central Retinal Vein Occlusion (CRVO)NL-OMON24763Oogziekenhuis RotterdamSchiedamsevest 1803011 BH Rotterdam48
终止
不适用
Evaluation of the Role of Intravitreal Tissue Plasminogen Activator in Treatment of Refractory Diabetic Macular EdemaDiabetic Macular EdemaNCT01141881Mashhad University of Medical Sciences
已完成
2 期
Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular EdemaDiabetic Macular EdemaNCT02712008Regeneron Pharmaceuticals302
进行中（未招募）
1 期
Investigation of effectiveness of intravitreal aflibercept treatment in special forms of exsudative maculopathiesEUCTR2014-002384-15-ATniversitätsklinik für Augenheilkunde und Optometrie50